EMD-45360

Single-particle
3.0 Å
EMD-45360 Deposition: 13/06/2024
Map released: 22/01/2025
Last modified: 29/01/2025
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-45360

Cryo-EM structure of TAP binding protein related (TAPBPR) in complex with HLA-A*02:01 bound to a suboptimal peptide.

EMD-45360

Single-particle
3.0 Å
EMD-45360 Deposition: 13/06/2024
Map released: 22/01/2025
Last modified: 29/01/2025
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: Complex of peptide loaded HLA-A*02:01/beta-2-microglobulin in complex with human TAPBPR.
Fitted models: 9c96 (Avg. Q-score: 0.522)

Deposition Authors: Pumroy RP, Mallik L, Sun Y, Moiseenkova-Bell YV, Sgourakis NG
CryoEM structure of an MHC-I/TAPBPR peptide-bound intermediate reveals the mechanism of antigen proofreading.
Sun Y, Pumroy RA , Mallik L, Chaudhuri A, Wang C, Hwang D, Danon JN , Dasteh Goli K, Moiseenkova-Bell VY , Sgourakis NG
(2025) PNAS , 122 , e2416992122 - e2416992122
PUBMED: 39786927
DOI: doi:10.1073/pnas.2416992122
ISSN: 1091-6490
ASTM: PNASA6
Abstract:
Class I major histocompatibility complex (MHC-I) proteins play a pivotal role in adaptive immunity by displaying epitopic peptides to CD8+ T cells. The chaperones tapasin and TAPBPR promote the selection of immunogenic antigens from a large pool of intracellular peptides. Interactions of chaperoned MHC-I molecules with incoming peptides are transient in nature, and as a result, the precise antigen proofreading mechanism remains elusive. Here, we leverage a high-fidelity TAPBPR variant and conformationally stabilized MHC-I, to determine the solution structure of the human antigen editing complex bound to a peptide decoy by cryogenic electron microscopy (cryo-EM) at an average resolution of 3.0 Å. Antigen proofreading is mediated by transient interactions formed between the nascent peptide binding groove with the P2/P3 peptide anchors, where conserved MHC-I residues stabilize incoming peptides through backbone-focused contacts. Finally, using our high-fidelity chaperone, we demonstrate robust peptide exchange on the cell surface across multiple clinically relevant human MHC-I allomorphs. Our work has important ramifications for understanding the selection of immunogenic epitopes for T cell screening and vaccine design applications.